News & Insights
Sort By
Insights 1 result
Insights
|March 5, 2024
BioPharma Quotes Tim Ehrlich in "Biotech IPOs heated up to start 2024. Will the surge last?"
BioPharma's article on the biotechnology sector's notable resurgence in IPOs quotes Gunderson Boston partner Tim Ehrlich.
Events 3 Results
Events
|October 27-28, 2025
Gunderson Dettmer Sponsors the Longwood Healthcare Leaders Boston CEO Summit 2025
Gunderson Dettmer co-sponsored the Longwood Healthcare Leaders Boston CEO Summit 2025, a two-day, invitation-only conference that convenes approximately 250 biopharma CEOs, R&D executives, government officials, life science investors, and leading academics for off-the-record discussions
Events
|October 16, 2025
“What’s Next in Biotech” In Conversation with Venrock Partner Bryan Roberts
Watch the Exclusive Premiere on What’s Next in Biotech with Gunderson Partner and Chair of Life Sciences Tim Ehrlich and Venrock Managing Partner Bryan Roberts
Events
|February 7, 2024
Webinar: “What’s Market” in University Licenses in the Life Science Industry
Gunderson Dettmer Strategic Transactions and Licensing partner Brendan McCarthy hosted the webinar “’What’s Market’ in University Licenses in the Life Sciences Industry” to discuss the key economic terms in university license agreements.
Client News 28 Results
Client News
|August 19, 2026
Amplitude Therapeutics Enters Strategic Collaboration With Lilly
Amplitude Therapeutics, a biotechnology company developing trans-amplifying RNA (taRNA) medicines and vaccines, announces its strategic research collaboration and licensing agreement with Eli Lilly and Company ("Lilly").
Client News
|July 24, 2025
TCG Labs Soleil Announces $400M Funding Raise
Venture firm integrating capital with an in-house biotech R&D hub, TCG Labs Soleil, announces its $400 million funding raise
Client News
|June 3, 2025
Hims & Hers Announces Definitive Agreement to Acquire ZAVA
Leading health and wellness platform, Hims & Hers, announces its definitive agreement to acquire Europe-based digital health platform, ZAVA
Firm News 9 Results
Firm News
|August 27, 2026
As part of its annual list of Massachusetts legal industry leaders, Massachusetts Lawyers Weekly (MLW) has once again recognized Boston partner and Life Sciences practice group chair Tim Ehrlich as a Go To Lawyer in the Health Care and Life Sciences practice area.
Firm News
|August 6, 2025
Joyce Hu Joins Gunderson Dettmer Beijing as Of Counsel
We are delighted to announce that Joyce Hu has joined our Beijing office as Of Counsel. Joyce is a valued member of our China and Life Sciences practice groups, where she focuses on representing emerging growth companies in the life sciences and technology sectors throughout their corporate lifecycles.
Firm News
|March 5, 2025
Gunderson Dettmer Welcomes Adrian Rich as a New Life Sciences Partner in Northern California
Gunderson Dettmer announces the addition of Life Sciences Partner, Adrian Rich, based in the Northern California offices